Also categorized in Global Health:
Targeting the Type I Interferon Pathway to Treat Patients With Lupus
x hide permanently

COVID Vaccination Less Effective for Those with Rheumatic, Musculoskeletal Diseases

Medical Xpress

Photo: Unsplash

medicalxpress.com

Johns Hopkins Medicine researchers recently reported that while two doses of a vaccine against SARS-CoV-2—the virus that causes COVID-19—confers some protection for people who have received solid organ transplants, it isn't sufficient to enable them to dispense with masks, physical distancing and other safety measures.

Now, the researchers have shown a similar lower-than-normal immune response to the messenger RNA (mRNA) COVID-19 vaccines for patients with rheumatic and musculoskeletal diseases (RMDs), conditions that often call for treatment with medications that suppress the immune system.

The study was detailed in a research letter published May ...